Organizing Committee
Melissa Carpenter, PhD
ElevateBio, USA
Derek Hei, PhD
Vertex Pharmaceuticals, USA
Malin Parmar, PhD
Lund University, Sweden
ISSCR 2022 Boston International Symposium
Given the rapid spread of the omicron variant, the ISSCR and the Boston International Symposium organizing committee are rescheduling the meeting, Translating Discoveries, to 17-19 November 2022. Registration is open. In person and virtual attendance options are available.
Join us for the ISSCR 2022 Boston International Symposium on Cell Manufacturing and Commercialization “Translating Pluripotent Stem Cell Discoveries to the Clinic: Preclinical, Manufacturing, and Regulatory Strategies for Success,” which will take place at the Boston Marriott Cambridge Boston, MA from 17-19 November 2022.
The meeting will bring together international academic and commercial scientists with expertise in the preclinical, clinical, and regulatory phases to discuss the critical processes and strategies in the successful development of PSC-derived therapies. Sessions will cover some of the latest thinking and approaches for selecting the cell line, characterizing the product and manufacturing considerations, managing the immune system, and working with regulators throughout the process. We hope you can join us in one of the world’s hubs of biotechnology.
Keynote Speaker
Peter Marks, MD, PhD
FDA Center for Biologics Evaluation and Research
Speakers & Topics
Preclinical Strategies
Doug Melton, PhD, Harvard University, USA
Su-Chun Zhang, MD, PhD, Duke-NUS Medical University, Singapore and University of Wisconsin-Madison, USA
Selecting Your Cell Line: Derivation and Characterization
Tenneille Ludwig, PhD, WiCell, USA
Nissim Benvenisty, PhD, Hebrew University Israel
Jennifer Dashnau, PhD, Century Therapeutics, USA
What’s in Your Product
Bahram (Bob) Valamehr, PhD, MBA, FATE Therapeutics, USA
Angela Keightley, PhD, BlueRock Therapeutics
New Technologies/Where Are We Going?
Daniel Paull, PhD, The New York Stem Cell Foundation (NYSCF)
Kapil Bharti, PhD, NIH, USA
Peter Zandstra, PhD, University of British Columbia, Canada
Immunology for Cell Therapies
George Daley, MD, PhD, Harvard University Medical School, USA
Sonja Schrepfer, MD, PhD, Sana Biotechnology, USA
Shin Kaneko, MD, PhD, CiRA, Kyoto University
Balancing Science and Regulatory Requirements in Emerging Fields
Anthony Oro, MD, PhD, Stanford University, USA
Gesine Paul-Visse, MD, Lund University, Sweden
Melissa Carpenter, PhD, ElevateBio, USA
How to Accelerate with Accelerated Designations
Daniel O'Connor, PhD, Medicines & Healthcare Products Regulatory Agency, UK
Jane Lebkowski, PhD, Regenerative Patch Technologies, USA
Masayo Takahashi, MD, Vision Care, Inc, Japan
Delivering Your Cell Product: Strategies for Success
Cory R. Nicholas, PhD, Neurona Therapeutics, USA
What to Expect
The ISSCR has created our International Symposia to delve into current stem cell topics through exciting scientific programs in an engaging, intimate atmosphere.
Learn about the latest science from a slate of global speakers
Present your research in an abstract-selected talk or a poster presentation
Connect with colleagues through numerous networking opportunities
Who Should Attend?
Academic, industry, and clinical researchers interested in stem cell biology and its therapeutic applications are encouraged to attend and share your latest research and
What Sets the International Symposia Apart?
ISSCR International Symposia are where the world's leading minds are building the future of stem cell science. They are
Sponsors
